# A Study of FVIII Gene Therapy for Hemophilia A

> **NCT05454774** · EARLY_PHASE1 · RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 8 (estimated)

## Conditions studied

- Hemophilia A

## Interventions

- **GENETIC:** Single dose intravenous injection of BBM 002

## Key facts

- **NCT ID:** NCT05454774
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-19
- **Primary completion:** 2024-12-15
- **Final completion:** 2027-09-15
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2025-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05454774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05454774, "A Study of FVIII Gene Therapy for Hemophilia A". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05454774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*